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Cleavage of Focal Adhesion Kinase in Vascular Smooth
Muscle Cells Overexpressing Membrane-Type
Matrix Metalloproteinases
Tomoko Shofuda, Ken-ichi Shofuda, Nicola Ferri, Richard D. Kenagy,
Elaine W. Raines, Alexander W. Clowes
Background—Membrane-type matrix metalloproteinases (MT-MMPs) were initially identified as cell surface activators of
MMP-2 (gelatinase A). We have reported that MT1-MMPs and MT3-MMPs are expressed by activated vascular smooth
muscle cells (SMCs) and play a role in the regulation of cell function. Overexpression of MT-MMPs results in cell
rounding, decreased adherence, and increased migration. Because integrin-mediated cell adhesion regulates these
events, we have investigated the functional relationship between MT-MMPs and focal adhesion assembly.
Methods and Results—Using adenoviral vectors we show that overexpression of MT-MMPs reduces the number of focal
contacts, whereas the cell surface expression of integrin subunits remains unchanged. The 125-kDa focal adhesion
kinase (FAK) is cleaved resulting in a 90-kDa fragment under these conditions, and paxillin is partially dissociated from
FAK after its cleavage. Pretreatment of cells with BB94, a synthetic MMP inhibitor, rescues cell adhesion and prevents
changes in focal adhesions, supporting a potential role for MT-MMP enzymatic activities.
Conclusions—This study provides the first evidence that MT-MMPs are not only important in matrix degradation but also
may affect the function of focal adhesions through FAK cleavage. (Arterioscler Thromb Vasc Biol. 2004;24:839-844.)
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Abnormal growth and migration of vascular smoothmuscle cells (SMCs) contribute to vascular diseases,
such as atherosclerosis and injury-induced intimal hyperpla-
sia.1,2 These processes require remodeling of the extracellular
matrix (ECM) surrounding the SMC, which alters their
interaction with the ECM. SMCs express a series of matrix
metalloproteinases (MMPs),3–5 zinc-dependent neutral pro-
teinases, which degrade surrounding ECM, such as collagens,
fibronectin, laminins, and proteoglycans.6–8 Membrane-type
MMPs (MT-MMPs), a subgroup of MMPs, have a transmem-
brane sequence and act at the cell surface. They were initially
identified as cell surface activators of MMP-2 (gelatinase
A),9,10 and we have reported that MT1-MMP and its closely
related molecule, MT3-MMP, are preferentially expressed by
activated SMCs both in vitro and in vivo.11,12 Recently, we
found that the overexpression of MT-MMPs in SMCs induces
changes in cell shape, adhesion, and migration, although the
precise molecular mechanism is still unclear.13
See cover
Cell adhesion is mediated through integrin-cytoskeletal
connections localized to the focal adhesion complex.14
Among numerous focal adhesion components, focal adhesion
kinase (FAK) is a nonreceptor cytoplasmic protein tyrosine
kinase associated with the cytoplasmic domain of integrin 
subunit.15–17 FAK is responsible for integrin-mediated signal-
ing to downstream molecules and connecting the adhesion
complex to cytoskeletal actin. FAK associates with focal
adhesion components, such as paxillin and talin, through its
carboxyl-terminal focal adhesion targeting (FAT) sequence.
The kinase activity of FAK is activated by the ligation of
integrin subunits to the ECM or by growth factors. Activated
FAK autophosphorylates tyrosine397 just upstream of the
kinase domain and transmits cell migration and growth
signals.15–17 The phosphotyrosine residue becomes a docking
site for the SH2-domain–containing Src family protein ty-
rosine kinases, which can, in turn, phosphorylate additional
tyrosine residues of FAK.
The function of FAK is controlled not only by phosphor-
ylation but also by cleavage. For example, degraded collagen
can induce the cleavage of FAK by activating calpain-like
intracellular proteinases in human SMCs.18 A similar pattern
of FAK cleavage by caspases has been observed in cells
undergoing apoptosis19–21 or fibroblasts transformed by the
v-src or myc oncogene.22,23 Under these conditions, FAK is
cleaved into an amino-terminal 85- to 100-kDa fragment
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containing integrin-binding and kinase domains and a
carboxyl-terminal 25- to 35-kDa fragment containing the
FAT sequence. Cleavage can perturb the functions of FAK
and alter its association with other focal adhesion proteins.18
The regulation of focal contacts is important not only for cell
adhesion but also for cell growth, migration, and survival. In
this study, we report that FAK is cleaved in MT-MMP–
overexpressing cells and that integrin-mediated cell adhesion
is reduced, even though cell surface expression of integrin
proteins is not changed. Possible roles of MT-MMPs in
regulating the function of focal adhesion in SMCs will be
discussed.
Methods
Materials
A hydroxamate inhibitor of MMPs, BB94 (Batimastat), was pro-
vided by British Biotechnology Ltd (Oxford, UK). Cytochalasin D
and monensin sodium salt were from ICN Pharmaceuticals (Costa
Mesa, Calif). Phalloidin conjugated with fluorescein isothiocyanate
(FITC) and ionomycin were from Sigma (Saint Louis, Mo). Pepsin-
digested type I collagen (Vitrogen) was purchased from Celtrix Co
(Richmond, Va). Antihuman integrin v (LM609) and 51 (JBS5)
monoclonal antibodies and an antihuman MT3-MMP polyclonal
antibody were purchased from Chemicon (Temecula, Calif). Anti-
human integrin 3 (P1B5), 1 (P4C10), and v5 (P1F6) monoclo-
nal antibody ascites were from LifeTechnologies (Rockville, Md).
Anti-MT1-MMP antiserum raised against a synthetic MT1-MMP
sequence in the hemopexin-like domain is a kind gift from Amgen
Inc (Seattle, Wash). An antipaxillin monoclonal antibody was from
Transduction Laboratories (Lexington, KY). Two different antibod-
ies against FAK were used, a polyclonal antibody recognizing the
amino-terminus (Santa Cruz Biotechnology, Santa Cruz, Calif) and a
monoclonal antibody against the kinase domain (Transduction Lab-
oratories, Lexington, Ky). Antirabbit IgG conjugated with FITC and
anti-mouse IgG conjugated with tetramethylrhodamine B isothiocya-
nate (TRITC) were from Zymed Laboratories (San Francisco, Calif).
Other chemicals were purchased from Sigma (Saint Louis, Mo).
Baboon aortic smooth muscle cells were cultured as described.13
Adenovirus Vector Development and Infection of
the Cells
Replication-defective adenovirus expressing rat MT1-MMP cDNA
and human MT3-MMP cDNA (AdMT1S and AdMT3, respectively)
were generated as reported.13 As a negative control, AdMT1AS,
which expresses rat MT1-MMP cDNA in an antisense orientation or
Ad-gal, which expresses -galactosidase cDNA, was used. All
adenoviruses were prepared at the University of Washington adeno-
virus core laboratory.24
SMCs (1106) were plated on a 10-cm dish 24 hours before
infection. Adenovirus was incubated with the cells at 3102 multi-
plicity of infection for 18 to 24 hours in 10% serum containing DME
medium. Cells were then switched to serum-free culture and media
conditioned by the cells or total cell lysates were recovered 12 to 72
hours after the incubation.
Indirect Immunofluorescent Microscopy
SMCs were plated onto plastic chamber slides (Nalge Nunc Inter-
national, Rochester NY), infected with adenoviruses, and cultured as
described. Cells were fixed with ice-cold acetone or 2% paraformal-
dehyde for 10 minutes and incubated with PBS containing 1% BSA,
1% goat serum and 0.1% Triton X-100 for 30 minutes. Incubation
with primary antibodies was overnight at 4°C, followed by second-
ary antibodies conjugated with FITC or TRITC, and in some cases
phalloidin conjugated with FITC. Fluorescence was analyzed by
laser microscopy.
Cell Adhesion Assay
Cell adhesion was evaluated as reported previously with slight
modifications.13 Briefly, cells infected with adenoviral vectors were
cultured for 72 hours in the absence of serum with or without BB94
(10 mol/L). Cells were suspended with trypsin, incubated in serum
to neutralize the trypsin, washed twice with DMEM, and resus-
pended in DMEM containing 1 mg/mL BSA. Cells (1.5104
cells/well) were plated in 96-well plates coated with anti-integrin
antibodies or with 3 g/mL of monomeric type I collagen. Ascites
fluids were diluted 1:500 and purified IgG was diluted to 4 g/mL
before coating. In some experiments, cell adhesion in the presence of
BB94 was also examined. After a 45-minute incubation at 37°C,
cells were washed with PBS to remove unattached cells, fixed with
formalin, stained with toluidine blue dye, and photometrically
quantified. Results are shown as the meanSD of 4 independent
experiments.
Flow Cytometry
SMCs were harvested with trypsin-EDTA (GIBCO/BRL), fixed with
2% paraformaldehyde, and incubated with the primary antibody in
PBS containing 0.2% BSA on ice for 2 hours. Samples were washed
3 times with PBS containing BSA and incubated with phycoerythrin-
conjugated goat anti-mouse IgG for 1 hour. After 3 washes, a
minimum of 5000 cells were analyzed using a FACScan flow
cytometer (Becton Dickinson).
Immunoprecipitation, Immunoblotting, and
Gelatin Zymography
Cells in 10-cm culture dishes were washed with PBS containing
1 mmol/L MgCl2 and 0.2 mmol/L CaCl2 and lysed in buffer containing
50 mmol/L Tris HCl (pH 7.4), 150 mmol/L NaCl, 15 mmol/L CHAPS,
1 mmol/L CaCl2, 1 mmol/L MgCl2, and proteinase inhibitors
(1.5 mol/L pepstatin, 50 mol/L leupeptin, and 5 g/mL aprotinin).
Immunoprecipitation was performed by adding primary antibody (1 to
2 g) and 10 L of a 50% slurry of agarose conjugated with protein A
or protein G (Roche Diagnostics, Indianapolis, Ind) overnight at 4°C
with constant rotation. After 2 washes with lysis buffer, immunopre-
cipitates were solubilized in 30 L of SDS sample buffer, separated on
10% polyacrylamide gels, and electrophoretically transferred onto
nitrocellulose membranes. After incubation with primary antibodies at
4°C overnight, bands were visualized by ECL (Amersham Biosciences
Corp, Piscataway, NJ).
Zymography was performed on 10% polyacrylamide gels contain-
ing 1 mg/mL of gelatin, as described previously.13
Statistics
Sources of significant variation were determined by using ANOVA
and the SNK test. Statistical significance was set at P0.01.
Results
Reduced Organization of Actin Filaments
and Focal Adhesions in MT-MMP–
Overexpressing Cells
As we previously reported, overexpression of MT-MMPs
induces SMC rounding, decreases adherence, and stimulates
migration.13 More than 90% of SMCs are transduced by this
adenoviral system.13We tested the possibility that MT-MMP
may perturb the assembly of focal adhesion complexes,
thereby affecting cytoskeletal arrangement in these cells.
Baboon SMCs infected with AdMT3 were cultured with or
without the MMP inhibitor, BB94, for 48 hours in the
absence of FCS. Cells were then fixed and stained with
phalloidin conjugated with FITC. In SMCs overexpressing
MT3-MMP, actin stress fibers are poorly organized and
accumulate in the periphery of the cells (Figure 1A). As
reported previously, the morphological changes in MT3-
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MMP–overexpressing cells are blocked in the presence of
BB94.13 In fact, when the cells are cultured with BB94
(10 mol/L), they show highly organized actin filaments
(Figure 1C), comparable to those in both normal uninfected
cells and control cells infected with Ad-gal (data not
shown). When MT3-MMP–overexpressing cells are stained
with anti-paxillin antibody, the staining tends to cluster
(Figure 1B). In the presence of BB94, however, paxillin
shows punctuate staining throughout the cell (Figure 1D).
These dots represent focal adhesion sites and the pattern of
uninfected and Ad-gal–infected cells is indistinguishable
(data not shown). Similar localization of actin and paxillin is
observed in MT1-MMP–overexpressing SMCs (data not
shown). These results suggest that the organization of focal
adhesions and actin filaments are reduced in cells overex-
pressing MT1-MMPs and MT3-MMPs and that enzymatic
activity is necessary for these changes. We are unable to
localize the MT1-MMP or MT3-MMP in the MT-MMP–
overexpressing cells because of the high background staining
with the antibodies.
Reduced Integrin-Mediated Cell Adhesion of the
MT-MMP–Overexpressing Cells
We examined the contribution of specific integrins to SMC
adhesion using a modified cell adhesion assay with specific
integrin antibodies on culture plates (Figure 2). Control cells
infected with Adgal or AdMT1AS adhere to the anti-3,
anti-1, and anti-51 antibody-coated plates to the same
extent as to type I collagen-coated plates, but not to normal
IgG coated plates. The poor adhesion of the cells to anti-v3
and anti-v5 antibodies is likely caused by the low expres-
sion of these integrins by these SMC (manuscript in prepa-
ration). Both MT1-MMP–overexpressing and MT3-MMP–
overexpressing cells show significant reductions (40% to
60%) in adhesion to all of the antibodies tested (P0.001
versus control AdMT1AS cells), and there are no differences
between MT1-MMP–overexpressing and MT3-MMP–over-
expressing cells.
To investigate whether the reduced adhesion requires
proteolytic activity of MT-MMPs, BB94 was used. As shown
in Figure 3, when cells are incubated for 3 days with BB94
before the adhesion assay, both 3- and 1-dependent adhe-
sion of MT-MMP–overexpressing cells is restored (P0.01
versus control). In contrast, BB94 has little effect on cell
adhesion when it is added during the assay (Figure I,
available online at http://atvb.ahajournals.org). These results
show that an extended exposure to the proteolytic activity of
MT-MMPs triggers the reduction of integrin-dependent cell
adhesion.
Because the observed reduction in cell adhesion may be
mediated by a reduction of integrin expression on the cell
surface, we performed flow cytometric analysis of integrin
expression. Baboon SMCs express substantial levels of 1,
2, 3, and 5 integrin subunits (median fluorescent inten-
Figure 1. Fluorescent staining demonstrates altered actin fila-
ment and paxillin localization in SMCs overexpressing MT3-
MMP. MT3-MMP–overexpressing SMCs were cultured without
(A and B) or with (C and D) 10 M BB94. Fixed cells were
stained with phalloidin conjugated with FITC (A and C) and with
antipaxillin monoclonal antibody, followed by a secondary anti-
body conjugated with TRITC (B and D). Fluorescence was ana-
lyzed by laser microscopy.
Figure 2. Integrin-mediated cell adhesion is reduced in SMCs
transduced with MT-MMP cDNAs. Baboon SMCs transduced
with MT1-MMP (MT1) or MT3-MMP (MT3) cDNA were plated
onto the 96-well ELISA plate coated with a series of integrin
function-blocking antibodies, collagen, or normal IgG. Control
cells were infected with AdMT1AS (MT1AS) or Ad-gal (-gal).
Cells were cultured with 10 M BB94 for 3 days before but not
during the assay. Adherent cells were fixed, stained, and quanti-
fied photometrically. Results are expressed as the meanSD of
4 wells. The results are representative of 3 independent
experiments.
Figure 3. BB94 rescues the adhesion defect of MT-MMP–over-
expressing cells. Cells infected with AdMT1 (MT1), AdMT3
(MT3), or control AdMT1AS (Ct) were cultured in the presence
or absence of 10 M BB94 for 3 days as indicated. ELISA
plates (96-well) were coated with anti-3 (3) or anti-1 (1)
integrin function-blocking antibodies. Cells were washed,
trypsinized, and plated onto the wells to evaluate the cell adhe-
sion. *P0.001, #P0.01.
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sity 101), but only low levels of v and 3 (median
fluorescent intensity 101) (manuscript in preparation). As
shown in Figure 4, overexpression of MT1-MMP or MT3-
MMP does not affect the cell surface expression of integrin
3 and 1 subunits. There is a subtle but reproducible
induction of 5 subunit expression, which seems to be
independent of the dramatic reduction in cell adhesion. We
also see the stable expression of integrin subunits on the cell
surface of MT-MMP–overexpressing cells by surface bioti-
nylation and immunoblot analysis (Figure II, available online
at http://atvb.ahajournals.org). Therefore, the observed reduc-
tion in cell adhesion in MT-MMP–overexpressing cells
cannot be explained by changes in levels of integrin subunits
on the cell surface.
Cleavage of FAK and Reduced Association of
Paxillin with FAK in MT-MMP–
Overexpressing Cells
In SMCs infected with AdMT1AS or Ad-gal, FAK is
detected as a single 125-kDa band in the presence or absence
of BB94 (10 mol/L; Figure 5A, upper). However, in both
AdMT1S and AdMT3-infected cells, the intensity of the
125-kDa band is decreased and a 90-kDa band appears. The
ratio of cleaved (90kDa) to total FAK is increased dramati-
cally (Figure 5B; P0.01 versus control AdMT1AS). BB94
reduces the level of FAK cleavage below that of control cells
(Figure 5B), suggesting that the enzymatic activity of MT-
MMPs is required for FAK cleavage. At least 1 mol/L BB94
is required to inhibit FAK cleavage effectively (Figure III,
available online at http://atvb.ahajournals.org). When SMCs
overexpressing MT1-MMP are preincubated 3 days with
BB94 and then the inhibitor is removed, the cleaved form
emerges 1 to 3 hours later. The pattern is similar to that of
MMP-2 activation, suggesting MT1-MMP may mediate both
events (Figure IV, available online at http://atvb.ahajournal-
s.org). Because FAK is immunoprecipitated with an antibody
recognizing the amino-terminus and detected by an antibody
against the kinase domain, cleavage of FAK must occur at the
carboxyl terminus. For the same reasons, the smaller 35-kDa
fragment of FAK cannot be detected by this method. Rep-
robing these blots with antibody against paxillin shows that
co-precipitation of paxillin with FAK decreases in MT1-
MMP–overexpressing and MT3-MMP–overexpressing cells
(Figure 5A, lower). In addition, both intact and cleaved forms
of FAK are detected in an immunocomplex with anti-1–
integrin antibody, suggesting that the cleaved form of FAK
associates with 1 integrin (Figure V, available online at
http://atvb.ahajournals.org). Thus, FAK cleavage might be
responsible for the reduction in focal adhesions and actin
filament organization.
FAK Cleavage by Endogenous MT-MMP Activity
To rule out the possibility that FAK cleavage was promoted
by nonphysiological levels of MT-MMP, normal SMCs were
stimulated with factors known to increase the expression or
activity of MMPs. Concanavalin A25 and cytochalasin D26
induce MMP-2 activation, whereas ionomycin prevents MMP
expression.27 Phorbol ester and monensin stimulate MT-
MMP expression in several cell lines.25,28 Both concanavalin
A and cytochalasin D activate MMP-2 (Figure 6) and
MT1-MMP protein expression (data not shown) in baboon
SMCs. Under these conditions, FAK cleavage is simulta-
neously observed, and both MMP-2 activation and FAK
cleavage are inhibited by BB94. In phorbol ester-stimulated
cells, we observe low levels of the FAK fragment, which are
not affected by BB94. Thus, induction of endogenous MT1-
MMP is associated with FAK cleavage and MMP-2
activation.
Figure 4. Cell surface expression of integrin subunits is not
altered in MT-MMP–overexpressing cells. SMCs infected with
AdMT1S (bold dotted lines) or AdMT3 (sparse dotted lines) and
uninfected control cells (solid lines) were trypsinized, fixed, and
incubated with anti-3 (left), 5 (right), and 1 (middle) antibod-
ies. To analyze the cell surface expression of integrin subunits,
cells were incubated with PE-conjugated goat anti-mouse anti-
body and analyzed by flow cytometry. In these experiments,
negative control staining was performed without first antibodies
(dotted lines). The results shown are representative of 3
experiments.
Figure 5. FAK cleavage is induced and the association of FAK
with paxillin is reduced in SMCs overexpressing MT-MMPs. A,
Cell lysates prepared from SMCs expressing MT1-MMP (MT1)
or MT3-MMP (MT3) cultured with () or without () 10 M
BB94 were compared with control cells infected with AdMT1AS
(AS) or Ad-gal (-gal). FAK was immunoprecipitated from the
lysates with an anti-FAK polyclonal antibody and detected by
immunoblotting with the monoclonal antibody (upper panel). The
same blot was reprobed with an antipaxillin monoclonal anti-
body (lower panel). Arrowheads, Immunoreactive bands
obtained by screening for FAK (upper panel) and paxillin (lower
panel), respectively. B, The ratio of cleaved (90 kDa) FAK to
total FAK was determined by densitometric analysis of 6 individ-
ual experiments (*P0.01).
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Discussion
Focal adhesion complexes regulate multiple cellular func-
tions including adhesion, survival, apoptosis, and migra-
tion.15–17 Among numerous proteins composing the focal
contact, FAK is especially important for connecting matrix-
integrin complexes with downstream signaling molecules and
actin stress fibers. In this study, we provide the first evidence
of the possible regulation of focal adhesions by cell surface
matrix metalloproteinase activity in SMCs. The overexpres-
sion of MT1-MMPs and MT3-MMPs reduces integrin-
mediated cell adhesion without changing the cell surface
expression and assembly of integrin subunits. Overexpression
of MT-MMPs is associated with FAK cleavage and partial
dissociation of paxillin from the integrin-FAK complex, all of
which are blocked by BB94. Loss of the FAK/paxillin
interaction may be a major contributor to the reduced orga-
nization of focal adhesions and actin filaments in cells
overexpressing MT-MMPs (Figure 1). As a result integrin-
mediated cell adhesion may be decreased.
The mechanism by which MT-MMPs mediate cleavage of
FAK is not clear including whether MT-MMPs cleave FAK
directly or indirectly. Some reports suggest an indirect
mechanism. Carragher et al reported that degraded collagen
can induce FAK cleavage and cell rounding,18 which is
relevant given the ability of MT1-MMP to degrade native
collagens.29 In this study, we demonstrated that FAK cleav-
age is directly catalyzed by intracellular calpain-like enzymes
and is inhibited by the membrane permeable calpain inhibitor,
ALLN.18 However, in MT1-MMP– overexpressing cells,
50 mol/L ALLN does not affect FAK cleavage (Figure VI,
available online at http://atvb.ahajournals.org). We were un-
able to test a higher concentrations because of its toxic effect
on baboon SMCs. Carragher et al also suggested that 2-
integrin mediates the effect of degraded collagen, because
among the integrin antibodies tested, only the function
blocking antibody against 2-integrin reduces FAK cleavage.
In contrast, none of the antibodies against integrin  subunits
affects FAK cleavage or the morphological changes in
MT-MMP–overexpressing cells (data not shown). Caspases
are also involved in FAK cleavage when cells undergo
apoptosis;19,21 however, ZVAD, a caspase inhibitor, does not
prevent cell rounding of MT1-MMP–overexpressing cells
and only partially inhibits FAK cleavage (Figures VI and VII,
available online at http://atvb.ahajournals.org). Under our
experimental conditions, the addition of 1 mol/L BB94
suppresses changes in focal adhesion (Figure 1) and the
majority of FAK cleavage in MT1-MMP–overexpressing
cells (Figure III). Importantly, this concentration is needed to
inhibit the activation of MMP-2 by MT1-MMP–expressing
cells,11 whereas BB94 inhibits soluble MMPs, such as
MMP-1, MMP-2, MMP-3, and MMP-9 at much lower
concentrations.30 Our results are consistent with MT-MMP–
mediated cleavage of FAK.
However, MT-MMPs are transmembrane proteases with
the reactive site in the extracellular space, whereas FAK is
located in the cytoplasm. Therefore, it is unlikely that
MT-MMPs could directly cleave FAK. However, Lee et al
reported that an MT-MMP–like activity can activate MMP-2
intracellularly when fibroblasts are cultured on a type I
collagen lattice.31 In addition, MT1-MMP is stored in an
intracellular compartment of tumor cells.32 We detect sub-
stantial levels of MT1-MMP and MT3-MMP in the 1%
Triton X-100 insoluble cytoskeletal fraction (data not shown).
It is known that a portion of FAK is also localized in the same
fraction, probably because of its tight connection to the
cytoskeleton.33 Still another possibility is that MT-MMPs
might cleave and induce the activation of some other cell
surface or extracellular proteins, which in turn directly induce
FAK cleavage. Our current model of these possibilities is
illustrated in Figure VIII (available online at http://atvb.aha-
journals.org). MT-MMPs could activate a FAK-cleaving
activity through their pericellular proteolytic activity or di-
rectly cleave FAK intracellularly. Either way, FAK cleavage
would promote the dissociation of actin filaments from the
focal adhesion complex where integrins-mediate cell/matrix
contact. Therefore, this might be the primary mechanism for
changes in cell shape and adhesion when MT-MMPs are
overexpressed.
In conclusion, our results suggest that MT-MMPs play a
role in modulating the function of focal adhesions. This is the
first report of the contribution of MT-MMP activity to the
function of focal adhesion complexes by a direct or indirect
effect on FAK. Recently, novel substrates and binding pro-
teins for MT-MMPs have been described including CD44,34
transglutaminase,35 claudin5,36 and 1 and 3 integrins.37
Future work will investigate whether one or more of these
proteins may mediate the modulation of focal adhesions
reported here.
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Figure 6. Induction of endogenous MT-MMPs is associated with
FAK cleavage and MMP-2 activation. Normal baboon SMCs
were starved for 24 hours and stimulated with concanavalin A
(ConA, 100 g/mL), phorbol ester (PMA, 100 ng/mL), cytochala-
sin D (CytD, 1 g/mL), ionomycin (Ion, 0.5 mM), monensin (Mon,
10 mM), or no stimulation (Ct) in the presence () or absence
() of BB94 for 24 hours. SMCs infected with AdMT1S were
also analyzed (MT1). Cells lysates were prepared and FAK was
immunoprecipitated and detected by immunoblotting (upper
panel). MMP-2 in the lysates was analyzed by gelatin zymogra-
phy (lower panel). Arrowheads, Immunoreactive FAK (upper
panel). Arrows indicate location of pro-mediate, intermediate,
and active forms of MMP-2 (lower panel).
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